Stock News

Can Asgn Incorporated (NYSE:ASGN)’s Tomorrow Be Different? The Stock Had Decline in Shorts

ASGN Incorporated (NYSE:ASGN) Logo

Investors sentiment decreased to 0.03 in 2018 Q2. Its down 0.54, from 0.57 in 2018Q1. It worsened, as 139 investors sold ASGN Incorporated shares while 4 reduced holdings. 2 funds opened positions while 2 raised stakes. 3.84 million shares or 88.77% less from 34.16 million shares in 2018Q1 were reported.
Frontier invested in 15,000 shares or 0.09% of the stock. 5,120 are owned by Eqis Capital. Eagle Boston Invest Management Inc has invested 1.97% of its portfolio in ASGN Incorporated (NYSE:ASGN). The Maine-based Schroder Investment Management Gru has invested 0.2% in ASGN Incorporated (NYSE:ASGN). Gemmer Asset Mgmt Lc reported 83 shares stake. Alpha Windward Ltd Liability Corporation invested in 0.01% or 189 shares. Usa Financial Portformulas has 0.02% invested in ASGN Incorporated (NYSE:ASGN) for 1,197 shares. Bamco has 1.71M shares.

Since May 14, 2018, it had 0 insider purchases, and 3 insider sales for $3.59 million activity. Another trade for 25,000 shares valued at $2.27M was sold by PIERCE EDWARD L. Hanson Theodore S. sold $1.15 million worth of stock or 12,409 shares. The insider MATIN ARSHAD sold $169,248.

The stock of Asgn Incorporated (NYSE:ASGN) registered a decrease of 8.65% in short interest. ASGN’s total short interest was 623,900 shares in November as published by FINRA. Its down 8.65% from 683,000 shares, reported previously. With 240,600 shares average volume, it will take short sellers 3 days to cover their ASGN’s short positions. The short interest to Asgn Incorporated’s float is 1.25%.

The stock decreased 3.34% or $2.38 during the last trading session, reaching $68.87. About 368,479 shares traded. ASGN Incorporated (NYSE:ASGN) has risen 68.99% since November 10, 2017 and is uptrending. It has outperformed by 53.37% the S&P500.

ASGN Incorporated provides IT and professional services in the technology, digital, creative, healthcare technology, engineering, life sciences, and government sectors in the United States, Europe, and Canada. The company has market cap of $3.61 billion. The company's Apex segment offers technical, digital, and creative and scientific professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients; IT staffing and consulting services comprising IT infrastructure, application development, project management, and healthcare IT professionals; and creative, marketing, advertising, and digital professionals. It has a 22.07 P/E ratio. It also provides scientific, engineering, and clinical research staffing and services for temporary and permanent assignments, such as chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, biostatisticians, drug safety specialists, SAS programmers, medical writers, food scientists, regulatory affairs specialists, lab assistants, and other skilled professionals.

ASGN Incorporated (NYSE:ASGN) Ratings Coverage

Among 4 analysts covering ASGN (NYSE:ASGN), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. ASGN has $94 highest and $67 lowest target. $80.25’s average target is 16.52% above currents $68.87 stock price. ASGN had 5 analyst reports since August 10, 2018 according to SRatingsIntel. Credit Suisse maintained ASGN Incorporated (NYSE:ASGN) on Thursday, October 25 with “Neutral” rating. The rating was maintained by BMO Capital Markets with “Outperform” on Thursday, October 25. As per Thursday, October 25, the company rating was maintained by Robert W. Baird. The rating was maintained by Wells Fargo on Thursday, October 25 with “Outperform”.

Another recent and important ASGN Incorporated (NYSE:ASGN) news was published by which published an article titled: “ASGN Incorporated to Participate in Investor Conference in November” on November 08, 2018.

ASGN Incorporated (NYSE:ASGN) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *